SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: bocaburgerman who wrote (993)5/15/1998 2:46:00 PM
From: David Cathcart  Respond to of 1826
 
Winston,

<< But I am wondering if MGI fits into the stock category "buy on rumor sell on news".>>

You know, it just might. Just think, you can now buy at $10 on the rumor that MGI 114 cures cancer in humans, and then sell at $100 when the news comes out that it does. :-)

David



To: bocaburgerman who wrote (993)5/15/1998 6:22:00 PM
From: seminole  Respond to of 1826
 
Winston

<<"buy on rumor sell on news". >>

This is what I plan to do. Yes, as long as this drug
is just rumored to work on cancer, I will be buying.
When the news is out about shrinking tumors in humans,
I may do some selling.

My predictions is that the first tumor shrunk will be
in one of the company's trials. ( I will go with Ovarian)

richard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News